The Thailand water pump market is anticipated to register a healthy CAGR during the forecast period. Factors fuelling market growth include low manufacturing costs, expansion of water Supply network, major urbanization, and industrialization, increasing arable land and land under cereal production.

Valley Cottage, NY -- (SBWIRE) -- 01/15/2019 -- Persistence Market Research (PMR) in its recent report titled, "Thailand Market Study on Water Pump: Industrial Segment to Witness Highest Growth by 2021", projects that the Thailand water pump market is expected to grow at a healthy CAGR of 6.3% during the forecast period.

In terms of revenue, the Thailand water pump market accounted for US$16.7 Million in 2014 and is projected to reach US$25.6 Million by 2021.Factors fuelling the market include low manufacturing costs, expansion of water supply network, massive urbanization and industrialization, increasing arable land and land under cereal production. Thailand is an agriculture-driven country. Growth in the agricultural sector, linked with increasing arable land and land under cereal production is leading to growing trend of micro irrigation in small farms, which is projected to increase deployment of centrifugal water pumps.

Similarly, the country is undergoing rapid economic growth and industrialisation and is also poised to emerge as a substantial market. It plays a crucial role as its one of the manufacturing hubs for water pumps. Deployment of monobloc pumps is increasing due to the growing trend of family farming, which is carried out on small agricultural plots and requires low HP centrifugal pump for micro irrigation. Pumps for domestic and agriculture application offer minimal product differentiation in terms of cost and quality. Similar buyer trends apply to both end-user segments.

Request Report TOC @ https://www.persistencemarketresearch.com/methodology/6197

On the basis of pump type, the submersible water pump segment is estimated to be the most dominant segment, with 63.5% of the overall Thailand water pump market share in 2015, followed by monobloc water pump segment with 36.5%share. Growth of the monobloc water pumps segment over the forecast period is expected to be driven by increasing demand for application in agro-industrial and food production purposes.

As of 2014, Thailand is among the world's top ten countries in terms of water consumption for agro-industrial and food production. Central & Eastern Thailand region was the largest market in terms of revenue contribution, accounting for 30.2% of the overall Thailand water pump market in 2014.The Bangkok area is one of the most prosperous parts of Central & Eastern Thailand and is a dominant contributor to the national economy, with the infertile Northeast being the poorest in similar terms.Southern Thailand market is projected to lose 80 BPS during the forecast period. The region is part of a narrow peninsula, with a distinctive climate and terrain. Its economy is based on rice cultivation and rubber production. Mountainous terrain and absence of large rivers are conspicuous features of this region.

By end-use application, the agriculture segment is projected to continue its dominance throughout the forecast period. Agriculture application segment is expected to gain 40 BPS during the forecast period as a major portion of the country's GDP is generated from agricultural activities. However, the industrial segment is forecasted to register the highest CAGR by 2021.Growth of the market in East Asia is mainly driven by increased adoption of water pumps in power plants, for development of new infrastructure, in heavy industry, municipal wastewater treatment plants, irrigation and drinking water facilities.

Key players in the Thailand water pump market includeGrundfos, KSB AG, Kirloskar Brothers Limited, Ebara Corporation. Global players like Grundfos, Sulzer Ltd, Flowserve Corporation focus on research and development initiatives to introduce innovative products to attain sustainable advantages over the competition. In addition, these players also focus on expanding their regional presence through mergers and acquisitions.

Request for sample report: https://www.persistencemarketresearch.com/samples/6197

Water pump manufacturers in Thailand usually sell their products via distributors, who account for approximately 80% sales share as compared to 20% share via direct sales.Global and regional players in Thailand water pump market focus on entering into long-term tie-ups with engineering, procurement, and construction (EPC) companies and distributors. Chinese players have tie-ups with retailers to enhance customer reach.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Future Market Insights has announced the addition of the “Home Automation Market" report to their offering.

Valley Cottage, NY -- (SBWIRE) -- 12/19/2018 -- Home automation provides high end solutions and uses advanced digital technology to automate our products and systems. Home automation provides better efficiency and better performance in automating the home or our household activities to centralized control the system. Consumers want to customized, they want professionally installed systems, which is at their convenience and easy to use. They want to save time, prefer energy efficient or saving products. In India, Honeywell and Tata Power Delhi Distribution announced their Automated Demand Response (ADR) project for industrial and commercial facilities. With the help of Honeywell technology, Tata Power Delhi distribution will link more than 160 buildings in its distribution network. It would include power management during periods of peak consumption.

Recently, SwannOne is launched by Swann security that allows users to control their security cameras, lights, AC's, locks through SwannOne app. It is a multi-faceted home automation system. This app is also compatible with cloud storage solutions and audio analytics. Mouser Electronics is collaborating with AirCorp, TE Connectivity, and Factory Automation System to announce a new Home and Factory Automation Series. This series is a part of Empowering Innovation Together program, which would focus on that would focus on innovative automation technologies that was only seen in science fiction TV shows or movies.

Home Automation Market: Drivers & Restraints

Increase demand of smart phone based app for home automation, increase consumer awareness about energy consuming products, technological advancement, convenience factor, rapid mobile connectivity, urbanization, and change in lifestyle are the most important driving factors, which are driving the growth of the home automation market. Since home automation provides safety, security and high advance technology advance, the demand for home automation market has increased.

Home automation products are not considered a necessity or a must buy. Their high initial installation cost is also very high, which is acting as a barrier for home automation market.

Request for Report Sample : https://www.futuremarketinsights.com/reports/sample/rep-gb-766

Home Automation Market: Segmentation

Home automation market is broadly classified on the basis of the following segments –

By Product:

Luxury home Automation System
Mainstream Home Automation System
Managed Home Automation System
DIY(Do It Yourself Home Automation System)
By Applications:

Safety and Security
Lighting
Entertainment (Audio and Video)
Heating, Ventilation and Air conditioning
Others
By Networking Technology:

Wired Home Automation System
Wireless Home Automation System
Computing Network Home Automation System
Others
Home Automation Market: Overview

The home automation market has grown substantially at a healthy CAGR due to advancement in technology. With rising disposable income and increasing demand for high end products which are energy consuming, home automation market is expected to grow globally. North America will emerge as the fastest growing region in home automation market in the forecast period.

Home Automation Market: Region-wise Outlook

The home automation market is expected to register a double-digit CAGR for the forecast period. Depending on geographic regions, home automation market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa. North America dominates the global home automation due to advancement in technology, consumer awareness and fast internet connectivity. North America is followed by Europe and Asia Pacific in the home automation market globally.

Home Automation Market: Key Players

Some of the key market players in home automation market are AMX, ADT Pulse, Control4 Corporation, Crestron, Vera, HomeSeer, SmartThings, Frontpoint, Savant, Siemens AG, Johnson Controls, Honeywell.

Request for Report TOC : https://www.futuremarketinsights.com/toc/rep-gb-766

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Future Market Insights has announced the addition of the “Amino Acids Market" report to their offering.

Valley Cottage, NY -- (SBWIRE) -- 12/19/2018 -- Twenty percent of human body is made up of protein. Protein plays a crucial role in almost all biological processes and amino acids are the building blocks of it. Thus supply of amino acids makes a positive impact on our bodies. Amino acid is a compound which is a rich source of protein. Hence they are used as supplements in food to increase human and animal productivity.

Amino Acids Market: Drivers & Restraints

In today's world a huge number of factors are responsible for preventing our bodies from getting stable supply of proteins. These factors include pollution caused by burning of fossil fuels, intensive use of fertilizers etc. This creates a need for intake of extra protein supplements which drives the market demand for amino acids.

Amino Acids Market: Segmentation

Major application areas of amino acid include food industry, as a livestock. For human consumption amino acids are mainly consumed as a sports nutrition to provide energy and endurance. It's mainly used to support body before and after exercise. Amino acid supplements are also advised as a preventive measure to avoid diseases like cardiovascular disease, gastrointestinal disorders, nervous system dysfunction, eye diseases etc. Use of amino acid to strengthen the food products is a new market trend in food industry.

In Livestock, amino acid supplement is mainly used in poultry, cattle, Aquatic animal, Swine and others. Animal feed industry is one of the biggest consumer of Amino acids. Amino acids are used as additives to help the growth of animals. Adding amino acid supplements to livestock's reduces animal waste releases. Amino acids can help dropping the consumption of crude protein thereby considerably cut feed cost, increase farm output, competitiveness and productivity of farm.

Request for Report Sample : https://www.futuremarketinsights.com/reports/sample/rep-gb-745

By types, amino acids can be segmented as Lysine, Methionine, Threonine and others. Methionine is a major source of revenue for amino acids which primarily finds application in poultry feed , well as Lysine is the fastest growing segments with major application in poultry and pig feed. Pig feed Industry is following the trend of replacing lysine corn and soybean protein, hence Lysine is anticipated to witness a huge growth in the future.

Amino Acids Market: Region-wise Outlook

In terms of region, Asia pacific is expected to witness during the forecast period owing to the increasing population and up gradation of lifestyle leading increasing demand for protein supplements for human consumption. Brazil, followed by Australia are also expected to generate a major share of revenue for amino acids owing to their exports of beef.

Amino Acids Market: Key Players

Key players in the amino acid products markets include Archer Daniels Midland Company(U.S), Evonik Industries AG(Germany, Amino GMbH,(Germany) Cargill (U.S), Daesang Corporation ( South Korea), Fufeng group company Ltd. (China) and Sunitomo Chemical Co. Ltd.( Japan).Major players are focusing on research and development to enter new market segments of amino acids.

Request for Report TOC : https://www.futuremarketinsights.com/toc/rep-gb-745

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Future Market Insights has announced the addition of the “Mushroom Materials Market" report to their offering.

Valley Cottage, NY -- (SBWIRE) -- 12/19/2018 -- Mushroom materials are developed from agricultural waste and other suitable materials which are completely biodegradable and free from any volatile organic compound content. These materials are the suitable alternatives for plastic and other synthetic based materials. The mushroom materials manufacturing process involves mixing agricultural by-products such as woody biomass, husks, cellulosic biomass, and other residual biomass with self-digesting crop residuals and other biomaterials. Fungi grows on the mixture for some days and the objects or molds are further cured to manufacture desired pieces needed for electronic components, spare parts and other accessories or components. These materials can be fabricated or molded into boards needed for furniture industry with considerable durability and working life.

Mushroom Materials Market: Drivers & Restraints

Mushrooms are good to eat, but their roots may be far more significant to manhood. They can be used to make mushroom based building materials that are stronger than concrete, have more insulating power than fiberglass, and are completely compostable. The drivers identified in growth of mushroom materials are eco-friendly characteristics, easier workability, and light weight than conventional materials which makes it easy to transport to distances. However, limited availability of the mushroom roots and other agricultural waste are the major constraints for the mushroom materials market.

Mushroom Materials Market: Segmentation

Mushroom materials market is segmented on the basis of geography, application and feedstock type. The application segment of the mushroom materials is further segmented into thermal insulation panels, building materials, protective packaging and others. On the basis of feedstock type, it can be further segmented into wood fiber, buckwheat hulls and cotton seed.

Request for Report Sample : https://www.futuremarketinsights.com/reports/sample/rep-gb-744

Mushroom MaterialsMarket: Region-wise Outlook

The global mushroom materials market is geographically segmented into seven key regions which are, North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan and Middle East & Africa.

The mushroom material is relatively new to the market and has been evolved over last decade, at present the market for this material is much concentrated in North American region but with increasing awareness among the industry players the adoption of this material is expected to grow in nearing future. The market for mushroom materials once hits mass commercialization; may exceed present growth potential multifold times across the globe. It may even outpace the growth of advanced materials which are currently exhibiting growth between 10% and 15% across the globe.

Mushroom Materials Market: Key Players

The market has currently few players operating at regional or domestic level. With the technological advancements and increasing degree of 'know-how' more market players are expected to join the competition. The only settled players identified in the mushroom materials market is Ecovative Design.

Request for Report TOC : https://www.futuremarketinsights.com/toc/rep-gb-744

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Future Market Insights has announced the addition of the “Enterprise Governance, Risk, and Compliance (eGRC) Market" report to their offering.

Valley Cottage, NY -- (SBWIRE) -- 12/19/2018 -- Global Enterprise Governance, Risk, and Compliance (eGRC) Market: Overview

Enterprise, governance, risk, and compliance (eGRC) is a framework which combines repositories for controls, risks, laws and regulations, assessments, and policies etc among compliance officers, risk managers, business owners and auditor. Enterprise governance, risk, and compliance (eGRC) solutions offer many benefits some of them are consolidation of governance, risk and compliance (GRC) elements, make better and well informed decisions, improve efficiency and effectiveness by reducing the chance of replication of processes etc.
Global Enterprise Governance, Risk, and Compliance (eGRC) Market: Segmentation

Global enterprise governance, risk, and compliance (eGRC) market is classified into solution, service, vertical, and region.The global enterprise governance, risk, and compliance (eGRC) market can be segmented on the basis ofsolution which includes audit management solution, policy management solution, compliance management solution, risk management solution, financial control management solution and other solutions. On the basis of service the market can be segmented into consulting, implementation service and support. Vertical wise, the global enterprise governance, risk, and compliance (eGRC) market is segmented into telecom sector, media & entertainment sector, healthcare sector, public sector, retail sector, transportation sector, manufacturing sector, and energy and utility sector. Region wise, global enterprise governance, risk, and compliance (eGRC) market is segmented into North America, Latin America, Western Europe, Eastern Europe, Japan, Asia Pacific Excluding Japan (APEJ), and Middle East and Africa (MEA).

Request for Report Sample : https://www.futuremarketinsights.com/reports/sample/rep-gb-735

Global Enterprise Governance, Risk, and Compliance (eGRC) Market: Region-wise Outlook

The global enterprise governance, risk, and compliance (eGRC) market is expected to witness a considerable growth in CAGR during the forecast period from 2015 to 2025. The enterprise governance, risk, and compliance (eGRC) is gaining traction across verticals, which in turn is expected to create huge growth opportunity for key players operating in the enterprise governance, risk, and compliance (eGRC) Market.

Global Enterprise Governance, Risk, and Compliance (eGRC) Market: Drivers

Organizations are becoming more aware regarding deployment of security solutions in their day to day business operations in order to secure and protect data and information from unauthorized access and cyber-attacks. In the past few years, number of cyber-attacks and data breaches have increased at a rapid rate. Therefore, growing number of risk factors against business data are expected to increase the adoption of security and compliance solutions across verticals, which in turn is expected to accelerate the growth of global enterprise governance, risk, and compliance (eGRC) market during the forecast period.

Global Enterprise Governance, Risk, and Compliance (eGRC) Market: Restraints

Lack of awareness within organization and fluctuating regulatory policies are acting as restraints for enterprise governance, risk, and compliance (eGRC) market, and are expected to hinder the growth of the market to some extent.

Global Enterprise Governance, Risk, and Compliance (eGRC) Market: Competitive Landscape

Key players in the global enterprise governance, risk, and compliance (eGRC) market focus on acquisition and mergers, offering advanced solutions and services in order to enhance customer experience and outperform competitors.

https://www.futuremarketinsights.com/toc/rep-gb-735

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

North America to be the Fastest Growing Region in the Global Knee Reconstruction Devices Market, Shows Domination Over Other Regions in 2017-2022 Period

Valley Cottage, NY -- (SBWIRE) -- 11/27/2018 -- Knee reconstruction is a surgical procedure that includes the relocation of ACL or anterior cruciate ligament which stabilizes the knee. In case of tear of this major knee component, it might cause the knee to give up during any kind of physical movement. Aging population is rising which experiences knee problems such as osteoarthritis or even rheumatoid arthritis. This has triggered the demand for knee reconstruction on a significant scale.

The technological advancements in medical science has introduced minimally invasive techniques which have enhanced the knee reconstruction procedure with increased precision, reduced complications, reduced time of surgery and enhanced accuracy. Various knee reconstruction devices are available, such as cementless implants, partial implants, cemented implants and revision implants which are widely applied in knee reconstruction surgeries. The improvisation and innovation of tools for knee surgeries have increased the demand for knee reconstruction surgeries, thereby showing a positive influence over the global knee reconstruction devices market.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-4878 ?

The global knee reconstruction devices market is expected to grow at a robust CAGR during the assessment period 2017 to 2022, and is anticipated to be valued at US$9.4 Bn by 2022 end.

6 Forecast Highlights on Global Knee Reconstruction Devices Market

North America region poised to dominate the global knee reconstruction devices market as it reflects high lucrativeness for the market growth during the 2017-2022 period and is expected to grow at a CAGR of 6.1%. Asia Pacific excluding Japan (APEJ) shows high potential of growth in the global knee reconstruction devices market

Cementless implants and partial implants segments by product type grow at a similar growth rate, however, cementless implants segment possesses high market share as of 2017 as compared to partial implants segment

Cemented implants by product type dominate the global market with respect to growth rate as well as market share by revenue throughout the 2017-2022 period and this segment is also expected to experience a high gain in the BPS the 2022 end. Cemented implants segment is anticipated to reflect a robust CAGR of 6.4%

Orthopaedic clinics segment by end user reflect highest growth rate during the period of assessment 2017-2022 and is growing at a huge CAGR of 7.1%

Hospitals segment by end user dominate the global market in terms of revenue, however, compared to orthopaedic clinics and ASCs segments, show low growth rate

Trauma segment by indication is poised to be the fastest growing segment and reflects a CAGR of 6.5% during the assessment period. Osteoarthritis segment by indication dominates the market with respect to higher revenue share in 2017 and is more likely to continue dominating the market in the coming years

Need more information about Report methodology ? @ https://www.futuremarketinsights.com/askus/rep-gb-4878  

The report has also profiled key leading players in the global knee reconstruction devices market, which would remain active through 2022. These include players like Tornier Inc., Japan Medical Dynamic Marketing, DJO Global, Exactech Inc., Arthrex Inc., United Orthopedic Corporation, Corin, Smith & Nephew, DePuy Synthes, Stryker Corporation and Zimmer, Inc.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Small Molecule API Market Segmentation Molecule - Standard API, High Potency API; Production – Captive/In-House, Outsourced; Application – Clinical, Commercial; Therapeutic Area - Cardiovascular Diseases, Respiratory Disorders, Infectious Diseases, Metabolic Disorders, Oncology, Immunology, Neurology, Urology, Dermatology, Ophthalmology, General Health, Others

Valley Cottage, NY -- (SBWIRE) -- 11/27/2018 -- A FMI study titled "Small Mole API Market" has highlighted that small molecule APIs continue to dominate the pharmaceutical market with fast U.S. FDA approvals for small molecule APIs in 2017. Small molecules are chemical substances composed of two or more atoms with molecular weight of less than 900 Dalton. In this report, the small molecule API segment is further categorized into standard API and high potency APIs. The U.S. FDA approved 34 new small molecule API entities in 2017. Growing accessibility to drugs and essential healthcare are fuelling the demand for small molecule API entities globally. Capacity of manufacturing is the single most important factor that holds back revenue the growth of the small molecule API market. Other restraining factors of the small mole API market include faulty standards in quality, flexibility of manufacturing, customer service and reliability.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-4591 

Industry leader Cambrex believes that the small molecule API market is witnessing an all-time high growth. The small molecule API market is large, very fragmented and there is growing trend of outsourcing. The major manufacturers of small molecule API note that the outsourced market accounts for over 50% of the small molecule API market in revenue terms. The small molecule API manufacturers are present mostly in North America, Europe and Asia Pacific. So are the contract manufacturers for small molecule APIs.

Small molecule APIs constitute ~65% of all pipeline drugs under development with leading drug regulators. Small molecule APIs in development have increased by 6% in 2017 over 2016. Small molecule APIs are rapidly advancing into late stages of development, which is increasing the demand for fill-finish contract manufacturing organizations. Furthermore, contract manufacturing and developing organizations specialized in small molecule APIs are making strategic investments to expand their service offerings for big clients. For example, contract manufacturing organizations are becoming a "one-stop-shop" for both small molecule APIs and finished forms in development and commercialization. This helps to maximize the synergy derived from the deals for more strategic partnerships between small molecule API manufacturers and others to keep predicting volumes and manufacturing requirements in check and visibility from an early stage. Pharma companies benefit when they are able to source small molecule APIs and finished dosage from a single CMO/CDMO. This minimizes the cost and complexity of the overall product, potentially reducing the time to market.

Increasing competition from local players is deterring the manufacturing of small molecule APIs. High competition from local small molecule API manufacturers is influencing the growth of the small molecule API market and is affecting the quality of the small molecule API produced. Increasing competition from local small molecule API manufacturers in terms of price is ultimately decreasing the profitability of multinational branded small molecule API manufacturers including small molecule manufacturing CMOs. As result, the captive small molecule API manufacturers are losing grounds in the Asian countries. These companies are facing challenges in terms of profitability and product margins.

Need more information about Report methodology ? @ https://www.futuremarketinsights.com/askus/rep-gb-4591 

Changing regulatory dynamics are hampering the growth of the small molecule API market. Supply chain security issues, facility contamination issues that could alter potency levels of small molecule APIs are leading to facility closures across emerging countries. This has a large impact on the cost of finished dosages of these small molecule APIs. The new entrants willing to enter into small molecule API manufacturing are facing financial challenges owing to aforementioned factors. This makes the market entry a costly decision for small and medium small molecule API manufacturers and contract manufacturing organizations. Such changing regulatory dynamics are hampering the growth of the small molecule API market in emerging countries.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Orthopaedic Bone Cement and Casting Materials Market Segmentation By Product Type - Bone Cement, Casting Materials (Plaster, Fiberglass, Others); By Application - Joint Arthroplasty, Trauma Cases, Sports Injury, Spine Surgeries, Others; By End User – Hospitals, Ambulatory Surgical Centres, Orthopaedic Clinic

Valley Cottage, NY -- (SBWIRE) -- 11/27/2018 -- In a recent global market study, the analysts of Future Market Insights examined the various factors impacting revenue growth of the global orthopaedic bone cement and casting materials market. An increasing prevalence of orthopaedic disorders and patient preference towards quality treatment for a better lifestyle are primarily responsible for fuelling market demand for orthopaedic bone cement and casting materials. The analysts have presented their forecasts along with the key market dynamics including revenue drivers, growth restraints, and market opportunities and trends in a new publication titled "Orthopaedic Bone Cement and Casting Materials Market: Global Industry Analysis 2012 – 2016 and Opportunity Assessment 2017 – 2027" that presents detailed forecasts of the global orthopaedic bone cement and casting materials market for a period of 10 years (2017 – 2027) by benchmarking the historical market estimations from 2012 to 2016.

Factors Impacting Revenue Growth of the Global Orthopaedic Bone Cement and Casting Materials Market

Future Market Insights analysis reveals the various factors that are likely to boost the growth in adoption of orthopaedic bone cement and casting materials. A growing number of people suffering from bone diseases such as osteoporosis, an increasing number of sports injuries and accidents leading to fractures of the bone, and the availability of advanced treatment options for severe back pain are some of the factors likely to drive the market towards high revenue growth in the coming decade.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-4825 

The global orthopaedic bone cement and casting materials market is also likely to witness a few trends in the near future. Growing research and development activities in the field of orthopaedics and increasing use of casting materials to treat orthopaedic injuries are expected to increase in the next few years, impacting the global market for orthopaedic bone cement and casting materials significantly.

Global Orthopaedic Bone Cement and Casting Materials Market: Regional Analysis & Forecast

Future Market Insights has tracked the performance of the global orthopaedic bone cement and casting materials market across the key geographies of North America, Latin America, Western Europe, Eastern Europe, Japan, APEJ, and MEA. Unsurprisingly, North America is the dominant regional market with estimated revenues in excess of US$ 1,400 Mn by the end of 2027, witnessing a CAGR of 5.1%. The APEJ orthopaedic bone cement and casting materials market is estimated to be valued at almost US$ 940 Mn by the end of 2027, recording an impressive CAGR of 9.7% – the highest among all the regional markets. The Western Europe regional market is slated to register a CAGR of 7.1% during 2017 – 2027.

Global Orthopaedic Bone Cement and Casting Materials Market: Segmental Forecasts

Forecast by Product Type: The global orthopaedic bone cement and casting materials market is segmented on the basis of product type into Bone Cement and Casting Materials. The Bone Cement segment is expected to be the most lucrative product type segment with an attractiveness index of 1.1 and a CAGR of 6.9% in terms of value.

Forecast by Application: The global orthopaedic bone cement and casting materials market is segmented on the basis of application into Joint Arthroplasty, Trauma Cases, Sports Injury, Spine Surgeries, and Others. Joint Arthroplasty is the most lucrative segment by application and also the largest, estimated to reach a market valuation of US$ 1,458.6 Mn by the end of 2027, registering a CAGR of 7.3%.

Forecast by End User: The global orthopaedic bone cement and casting materials market is segmented on the basis of end user into Hospitals, Ambulatory Surgical Centres, and Orthopaedic Clinics. Hospitals is the largest end user segment, estimated to reach a market valuation of just under US$ 2000 Mn and witness a growth rate of 7.0% between 2017 and 2027.

Need more information about Report methodology ? @ https://www.futuremarketinsights.com/askus/rep-gb-4825 

Global Orthopaedic Bone Cement and Casting Materials Market: Competitive Landscape

The report profiles some of the top companies operating in the global orthopaedic bone cement and casting materials market such as DJO Global, Inc., Heraeus Holding, Zimmer Biomet, BeneCare Medical, BSN medical, Stryker, 3M Health Care Ltd., DePuy Companies (Sub. Johnson & Johnson Services, Inc.), Smith & Nephew Plc, Exactech, Inc., Medtronic, Inc., B. Braun Melsungen AG, Cook Medical, SOMATEX® Medical Technologies GmbH, TEKNIMED, T-Tape Company B.V., Lohmann & Rauscher GmbH & Co. KG, MIKA MEDICAL, Oessur, and Innovation Rehab LTD.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Companion Animal Speciality Drugs Market By Product Type – Antibiotics, Anti-inflammatory Drugs, Parasiticides, Heartworm, Behavioural Products, Nutritional Products, Anti-Obesity Drugs, Skin Care Products, Vaccines; By Distribution Channel – Veterinary Hospitals, Veterinary Clinics, Pharmacies and Drug Stores

Valley Cottage, NY -- (SBWIRE) -- 11/27/2018 -- Rapid urbanisation and commonness of isolated family units in the modern world are two of the major reasons that have led to increasing humanization of animals. The trend of pet adoption as companions has been rising all over the world, fueling the demand for veterinary products. A recent study conducted by Future Market Insights (FMI) reveals that revenues from the worldwide sales of companion animal specialty drugs are expected to reach US$ 29,151.5 Mn by 2017-end. The global companion animal specialty drugs market is expected to witness a CAGR of 4.9% in terms of revenue between 2017 and 2027. 

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3984 

FMI's report titled "Companion Animal Specialty Drugs Market: Global Industry Analysis and Opportunity Assessment 2017-2027" also projects that sales of animal specialty drugs will remain high in regions such as North America, Western Europe and Asia Pacific excluding Japan (APEJ) during the forecast period. In 2016, North America accounted for around 33% revenue share of the market mainly due to the adoption of innovative service delivery models by most retailers in the region. In addition, the companion animal specialty drugs market in North America will continue to be highly lucrative over 2027.

Towards the end of assessment period, parasiticides animal specialty drug is estimated to garner US$ 17,750.7 Mn in revenues. Among all the product types, demand for parasiticides will continue to gain the highest traction over the next couple of years. Moreover, expansion of distribution networks, especially in emerging countries is anticipated to further boost the sales of such companion animal specialty drugs. Manufacturers are also laying greater emphases on product and process innovation in order to improve their product portfolio as well as to offer better drug options. The market is dominated by top four players, Elanco, Merial, Zoetis, Inc. and Bayer AG, which collectively account for nearly two-third of the market share in terms of revenue. Merck and Co., Inc, Boehringer Ingelheim GmbH, and Ceva Sante Animale are among other key players that have a healthy presence in the global companion animal specialty drugs market.

Key Highlights of the Report Include: 

Rising cases of pet obesity fueling the demand for medicines. Pet obesity has become quite prevalent, owing to the rising tendency to overfeed pets. Extensive feeding can make a negative impact on the health of pets, therefore making them susceptible to more diseases.

Of late, higher importance to animal health and welfare has been observed in developing countries. This, in turn, is positively influencing the demand for compounded medication. Also, the need for easy access to services and affordable veterinary drugs is a major factor that is increasing the popularity of compounded drugs across the globe.

The arrival of new technologies, especially in biologics such as recombinant DNA vaccines for dogs are expected to eventually drive demand for specialties in veterinary medicines in 2017 and beyond.

On the basis of distribution channels, veterinary clinics account for more than one-third of the market share. Around US$ 12,446.3 Mn worth companion animal specialty drugs are expected to be distributed through veterinary clinics in 2017.

Need more information about Report methodology ? @ https://www.futuremarketinsights.com/askus/rep-gb-3984 

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Oral Controlled Release Drug Delivery Technology Market Segmentation By Drug Release System - Diffusion Controlled Release System, Dissolution Controlled Release System, Osmotically Controlled Release System, Dissolution & Diffusion Controlled Release System, Ion Exchange Resins Controlled Release, Hydro-dynamically Balanced Drug Delivery System, Others; By Dosage Form - Solid Dosage Forms, Semisolid, Liquid/Suspensions

Valley Cottage, NY -- (SBWIRE) -- 11/27/2018 -- Future Market Insights (FMI), in its report, projects the global oral controlled release drug delivery technology market to register an impressive expansion at 7.2% CAGR during the forecast period 2017 to 2027. The market will surpass revenues worth US$ 20,000 Mn in 2017, and is further estimated to reach nearly US$ 50,000 Mn by 2027-end.

Oral Solid Dosage Manufacturers in North America Enabled to Achieve Significant Bioavailability

FMI's report estimates North America to remain the largest market for oral controlled release drug delivery technology, with sales estimated to reach nearly US$ 20,000 Mn by 2027-end. Being preferred route of drug administration by physicians, demand for oral controlled release drug delivery technology has been witnessing a surge by end-users in North America. In addition, recent advancements in drug delivery have enabled oral solid dosage manufacturers in North America to achieve significant bioavailability through adoption of novel drug delivery platforms. This is further expected to drive demand for oral controlled release drug delivery technology in the region.

However, increasing research activities related to biologic molecules, and their dominance in treating oncology conditions, coupled with government investments in these research activities are expected to impede the market growth in North America. In addition, formulation challenges such as juncture of market expectations for once-daily dosing, and growth of controlled release tablets which impart abuse resistance, incurred in oral controlled release drug delivery technology are expected to further curb growth of the market in this region.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-4400 

New Chemical Entities Resulting from High Throughput Screening to Drive Market Growth in Western Europe

Western Europe will register the fastest expansion in the global oral controlled release drug delivery technology market. This growth is primarily attributed to a slew of new chemical entities resulting from high throughput screening, which have low solubility and bioavailability. This has further led manufacturers in this region to invest in drug delivery methods with better clinical outcome. Owing to cost-sensitiveness in Western European countries, technologies enhancing bioavailability will remain preferred drug delivery system. These factors are expected to drive growth of the market in this region.

However, most of the pharmaceutical companies in Western Europe have complex supply chain, which is either under-utilised or inefficient. Complexity of supply chain is attributed to low flexibility and cost-effectiveness. In addition, shortening of effective patent life along with patent cliffs is a major challenge for oral solid dosage forms in this region. Factors such as these are estimated to hinder growth of the market in Western Europe.

Dissolution-Controlled Release System to Remain Sought-After among Drug Release Technologies in the Market

By drug release technology, dissolution-controlled release system will remain sought-after in the market, followed by diffusion-controlled release system. Majority of generic formulations available are in tablet dosage form and follow dissolution-controlled release mechanism. Revenues from sales of dissolution-controlled release system will surpass US$ 10,000 Mn in 2017. Demand for hydrodynamically-balanced drug delivery system will remain sluggish in the market.

Need more information about Report methodology ? @ https://www.futuremarketinsights.com/askus/rep-gb-4400 

Solid dosage forms of oral controlled release drug delivery technology are expected to remain dominant in the market, expanding at a high single-digit CAGR through 2027. Sales of semisolid/liquid/suspensions dosage form segment will register a comparatively lower CAGR than that of solid dosage forms in the market through 2027.

Key market players identified in FMI's report include AstraZeneca Plc., Bristol-Myers Squibb Company, Sun Pharmaceuticals Industries Ltd, Abbott Laboratories, Merck & Co. Inc.,Novartis AG, Pfizer Inc., Mylan N.V., Sanofi, F. Hoffman-La-Roche Ltd., Johnson & Johnson Services, Inc., Vectura Group plc., GlaxoSmithKline plc.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Smart Insulin Pens Market Segmentation By Indication – Diabetes Type I, Diabetes Type II; By Connectivity – Bluetooth Connected Smart Insulin Pen, USB Connected Smart Insulin Pen; By Distribution Channel – Clinics and Ambulatory Surgical Centres, E-Commerce, Retail Pharmacies

Valley Cottage, NY -- (SBWIRE) -- 11/27/2018 -- Increasing pool of diabetic patients witnessed across the globe has prompted leading manufacturers of medical devices towards development of ground-breaking products. Smart insulin pens are among such devices that have revolutionised the global market for diabetic injection pens. A recent study published by Future Market Insights projects that the global smart insulin pens market, which is currently valued at US$ 0.86 Mn, will expand vigorously at 17.9% CAGR through the end of 2027. During this ten-year forecast period, the global demand for smart insulin pens is estimated to surge rapidly as medical device manufacturers will be actively adopting advanced technologies that deliver cutting-edge devices.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1827

While the parent market – global diabetic injection pens market – is presently worth US$ 4.9 Bn, contribution of revenues arising from global sales of smart insulin pens will remain minimal. Nevertheless, the global smart insulin pens market will bring in more than US$ 4 Mn revenues by the end of 2027. The report, titled "Smart Insulin Pens Market: Global Industry Analysis and Opportunity Assessment, 2017-2027," also reveals that Europe will emerge as a dominant region for growth of global smart insulin pens market. Sales of smart insulin pens across European countries are anticipated to bring in over US$ 2.4 Mn by end of 2027.

Meanwhile, awareness regarding smart insulin pens is expected to rise robustly across the US and Canada. North America's smart insulin pens market is, thus, estimated to register revenue growth at a staggering 26.7% CAGR. Through 2027, sales of smart insulin pens across Asia-Pacific region are also projected to gain traction, bringing in a little over US$ 1.2 Mn in revenues.

Key Trends Driving the Demand for Smart Insulin Pens

A crucial factor fuelling the global sales of smart insulin pens is higher dependency of patients & medical professionals on data obtained from clinical trials. Conventional devices are unable to offer facilities that are provided through smart insulin pens. The demand for smart insulin pens is also driven by preference of health insurers towards outcome-based compensation models. Moreover, medical device manufacturers are looking at profitable opportunities arising from rising adoption of medical management processes, increasing development of insulin adherence programs, and higher demand for patient-centric devices. It has been estimated that during the forecast period, the global market for smart insulin pens will witness active participation from three medical device manufacturers – Companion Medical Inc., Emperra GmbH E-Health Technologies and Digital Medics Pty Ltd.

The report further reveals that a majority of smart insulin pens sold across the world will be purchased for treatment of type II diabetes. The demand for smart insulin pens among type I diabetics is expected to remain considerably lower, procuring global revenues of just over US$ 700,000. Connectivity of smart insulin pens is also observed as a key aspect impacting the market's growth. And, the report projects the global smart insulin pens market to remain equally split between Bluetooth and USB-connected pens through the end of 2027.

Need more information about Report methodology ? @ https://www.futuremarketinsights.com/askus/rep-gb-1827

The report also expects clinics and ambulatory surgical centres (ASCs) based across the globe as the largest distribution channels for smart insulin pens. In 2017, close to 88% of global smart insulin pens revenues are likely to be accounted by clinics and ASCs. On the other hand, proliferation of online commercial platforms will also play a key role in distribution of smart insulin pens. Throughout the forecast period, e-Commerce distribution channels are expected to exhibit revenue growth at more than 24% CAGR.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Safety Needles Market Segmentation By Product Type - Fine Aspirating Needles,Biopsy Needles,Hypodermic Needles,Pen Needles,Suture Needles,IV Catheter Needles,Blood Collection Needles,Spinal Anesthesia and Epidural Needles,Prefilled Needles,A.V. Fistula Needles,Cannula Needles,Huber Needles; By Application Type - Sample Collection,Drug Delivery

Valley Cottage, NY -- (SBWIRE) -- 11/27/2018 -- The sole purpose of designing safety needles was to avoid needlestick injuries while collecting fluids and delivering drugs to the body. The key players of global market for safety needles are enhancing their product portfolio by focusing on production of innovative needles with safety features. These players include B. Braun Melsungen AG, Novo Nordisk A/S, Medtronic, and Becton, Dickinson and Company. Becton, Dickinson and Company holds its dominance in the overall market with around 50% share, followed by Medtronic and Novo Nordisk AS. Future Market Insights' recent report profiles Smith Medical and Argon medical Inc. as emerging safety needle manufacturers, while Terumo Medical Corporation and Boston Scientific Inc. are recognised as mid-level players in the global safety needles market.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-2029 

Rising Focus on Use of Prefilled Syringes Fuelling the Demand

At present, value of the global safety needles market is estimated to be s worth US$ 3,752.2 Mn, and it is estimated to reach US$ 7,765.7 Mn by 2027-end, witnessing a CAGR of 6.9% during this forecast period. The growing focus on utilization of prefilled syringes for treatment of several ailments is fuelling the demand for safety needles across the globe. Factors such as changing lifestyle habits, exposure to hormones and infection by HCV are expected to result in gynaecological cancers. Rising incidence rate of gynaecological cancers, coupled with higher presence of lower-back problems in regions such as the US are driving the demand for spine needles and other types of safety needles.

Trends Observed in the Global Safety Needles Market

Leading companies are participating in campaigns in co-ordination with governments of several economies for raising awareness about unsafe use of reusable needles among patients. Increasing prevalence of HIV & blood-borne diseases, owing to needle injuries, has also urged the companies for development of needles with enhanced safety features.

Key findings from FMI's Report Include

Hypodermic needles, as a product, will dominate the market, and is expected to account for 18.1% share during the forecast period. However, biopsy needles are expected to witness fastest revenue growth at 8.6% CAGR.

Hospital pharmacies are estimated to account for more than half of safety needles being distributed globally, while private clinics are expected to garner over US$ 1,300 Mn through 2027.

Drug delivery application of safety needles is expected to gain 242 BPS in its market share. In addition, sample collection is projected to create an absolute $ opportunity of around US$ 1,840 Mn in 2017 over 2016.

Need more information about Report methodology ? @ https://www.futuremarketinsights.com/askus/rep-gb-2029 

APEJ - Fastest-Growing Safety Needles Market in World

Around 24% market share is estimated to be held by Western Europe by the end of 2027, while APEJ is expected to register fastest growth in the global market for safety needles. In contrast, Eastern Europe is poised to depict a sluggish growth during the forecast period, while North America is will remain the outright dominant region in the global market for safety needles.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Endovenous Laser Therapy Market Segments By End User - Hospitals, Ambulatory Surgical Centres and Specialised Clinics, By Product - Endovenous Laser Systems (Diode Lasers and YAG Lasers), Endovenous Laser Fibres (Bare Tip Laser Fibre, Radial Tip Laser Fibre and Gold Tip Laser Fibre)

Valley Cottage, NY -- (SBWIRE) -- 11/27/2018 -- Obese people are seldom prone to health implications arising from increasing caseload for varicose veins in their body. The rising number of obesity cases recorded across the globe are prompting the adoption of endovenous laser therapy for treatment of varicose veins. A latest study on global endovenous laser therapy market, published by Future Market Insights, indicates that growing attention towards aftereffects of lifestyle choices and consequences of obesity have collectively factored the growth in demand for endovenous laser therapies. With the help of this minimally-invasive therapy, which is guided by ultrasound laser techniques, vascular surgeons and radiologists can effectively treat impaired varicose vessels and curb the occurrence of side effects such as temporary paraesthesia.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-2785 

The report, titled "Endovenous Laser Therapy Market: Global Industry Analysis and Opportunity Assessment, 2016-2026," reveals that an estimated US$ 273.6 million revenues were procured, globally, from adoption of endovenous laser therapy in 2016. Key findings compiled in the report predict that by the end of 2026, the global market for endovenous laser therapy will be valued at a little over US$ 550 million, registering increment at an impressive CAGR of 7.3%.

In 2016, nearly 8,500 units of endovenous laser therapy equipment were consumed in the world. The demand for such equipment and devices is projected to soar at close to 8% CAGR and record the sales of more than eighteen thousand units by the end of 2026. An in-depth analysis of the global sales of endovenous laser therapy equipment indicated that the demand for endovenous laser systems will remain prodigiously higher than that of endovenous laser fibres. Throughout the forecast period, more than 90% of global revenues will be emanating from global sales of endovenous laser systems. Among them, preference to diode lasers will continue to outpace the adoption of YAG laser systems. And, with respect to the fibres used in endovenous laser therapy, gold-tip laser fibres will gain traction and register a revenue growth at 7.2% CAGR.

The advanced operational infrastructure in hospitals and availability of trained medical professionals make them suitable for conducting endovenous laser therapies effectively. However, ambulatory surgical centres (ASCs) located around the world are witnessing advancements in terms of their working mechanism. In 2017 and beyond, hospitals will witness a gradual decline of their global revenue share whereas ASCs emerge to be the largest end-user of endovenous laser therapy in the world.  By 2026-end, more than US$ 200 million worth of revenues will be accounted by adoption of endovenous laser therapy through ASCs.

AngioDynamics, Inc., is a US-based medical device manufacturer which has gained prominence as a key player in the global endovenous laser therapy market. Correspondingly, North America's share in the global market for endovenous laser therapy is also expected to remain dominant through 2026; procuring over 50% share of global revenues. Nevertheless, the Asia-Pacific excluding Japan (APEJ) region will see rampant growth in demand for endovenous laser therapy. Revenues from this region are anticipated to surge at the highest CAGR of 7.9%. Meanwhile, Western Europe will be observed as the second-largest market for endovenous laser therapy, placing itself between North America and APEJ region.

Need more information about Report methodology ? @ https://www.futuremarketinsights.com/askus/rep-gb-2785 

European companies such as Dornier MedTech GmbH, Alna-Medicalsystem GmbH, LSO Medical, intros Medical Laser GmbH, and Energist Ltd. will continue to actively participate in the growth of global endovenous laser therapy market. Besides, Wontech Co. Ltd., Alma Lasers Ltd., and Syneron Medical Ltd. are also recognised as leading manufacturers of endovenous laser systems in the world.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Widefield Imaging Systems Market Segmentation By Indication - Diabetic Retinopathy, Retinopathy of Prematurity, Pediatric Retinal Diseases, Retinal Vein Occlusion, Ocular Oncology, Uveitis, Chorioretinal Diseases, Glaucoma; By Component – Instruments, Software (Image Viewing & Data Analysis and Interpretation Software); By Modality – Standalone, Portable; By End User - Specialty Clinics, Hospitals, Ambulatory Surgical Centres

Valley Cottage, NY -- (SBWIRE) -- 11/27/2018 -- Advanced imaging systems are becoming the crux of all intricate medical procedures, especially for methods that treat ailments of sensitive body parts & organs. Widefield imaging systems are known to play a similar role in treatment of various eye disorders and diseases. One wrong touch to the naked eye can, not only irk the patient, but also give rise to tremendous physical discomfort and lead to undue exposure to infectious diseases. Medical professionals, hence, are promoting the use of widefield imaging technologies for assisting the imaging purposes in treatment of ocular oncology, diabetic retinopathy and other retinal diseases. A recent study conducted by Future Market Insights illustrates that diabetic retinopathy accounted for over one-third of global widefield imaging systems revenues in 2016.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1732 

According to Future Market Insights –

The global market for widefield imaging systems, which is presently valued at US$ 385.8 million, will soar at 8% CAGR and bring in revenues worth US$ 834.5 million by the end of 2026.

Diabetic Retinopathy will account for over US$ 320 million revenues by 2026-end, procuring nearly 40% of the global market value.

Demand for widefield imaging systems will be high for treatment of glaucoma, registering an increment at 9.2% CAGR.

Apropos the report titled "Widefield Imaging System Market: Global Industry Study and Opportunity Assessment, 2016-2026," North America is projected to account for more than 40% of global revenues throughout the forecast period. Sales of widefield imaging systems in Asia-Pacific excluding Japan (APEJ) region will surpass US$ 130 million by 2026-end. Latin America and the Middle East & Africa (MEA) regions are likely to exhibit sluggish growth, compared to Western Europe and Eastern Europe's widefield imaging system market. Meanwhile, Japan's widefield imaging systems sales will surpass US$ 65 million revenues by the end of forecast period.

European medical device manufacturers are observed to play key role in the global widefield imaging system market. Some of the leading manufacturers of widefield imaging systems include Centervue SpA (Italy), Optos plc, Carl Zeiss Meditec (Germany) and Heidelberg Engineering GmbH (Germany). US-based companies Visunex Medical Systems, Inc. and Clarity Medical Systems, Inc. are also observed as key players in the global market for widefield imaging systems.

Highlights of the research on global widefield imaging system market include:

Hospitals will remain the largest end-user of widefield imaging systems, accounting for global revenues worth over US$ 300 million by 2026-end

Need more information about Report methodology ? @ https://www.futuremarketinsights.com/askus/rep-gb-1732 

Throughout the forecast period, demand for standalone widefield imaging systems will remain higher. Although, portable modality of using widefield imaging systems will gain traction.

While sales of instruments will remain higher compared to software used in widefield imaging systems, data analysis & interpretation software are likely to witness higher demand over the forecast period

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

GCC Medical Gloves Market Segmentation By Product Type – Examination, Surgical, and Chemotherapy Medical Gloves; By Type of Raw Material - Latex Material, Nitrile Rubber, Vinyl Rubber, Polyisoprene Medical Gloves; By Form – Powdered and Powder-Free Form Medical Gloves; and Others

Valley Cottage, NY -- (SBWIRE) -- 11/26/2018 -- The GCC medical gloves market is estimated to increase from US$ 99.5 Mn in 2016 to US$ 240.8 Mn by 2026, registering a CAGR of 9.2% over the forecast period 2016–2026, according to a latest report titled "GCC Medical Gloves Market: Industry Analysis & Opportunity Assessment, 2016-2026" published by Future Market Insights. 

According to Future Market Insights analysts, an increasing awareness regarding hygiene and health and safety is boosting the growth of the GCC medical gloves market. A growing prevalence of pandemic diseases such as Swine flu (H1N1 pandemic), HIV, and Acquired Immunodeficiency Syndrome (AIDS); and an increase in the number of elective treatments such as plastic surgery, liposuction, rhinoplasty, breast augmentation, breast reduction, facial rejuvenation, and blepharoplasty are some of the other factors augmenting market growth. 

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gc-1943

Segmentation highlights

The GCC medical gloves market has been segmented on the basis of Product Type (Examination Gloves, Surgical Gloves, Chemotherapy Gloves); Form (Powdered Form Gloves, Powder-Free Form Gloves); End Use (Hospital Use, Clinic Use, Ambulatory Surgery Centre Use, Diagnostic Imaging Centre Use, Rehabilitation Centre Use); Type of Raw Material (Latex Material Gloves, Nitrile Rubber Material Gloves, Vinyl Rubber Material Gloves, Polyisoprene Material Gloves); Type of Use (Disposable Medical Gloves, Re-usable Medical Gloves); and Distribution Channel (Direct Selling Channel, Medical Store Channel, E-Commerce Channel, Other (Retail Store or Hypermarket) Channel).

The examination gloves segment is estimated to be valued at US$ 56.5 Mn by the end of 2016 while the surgical gloves segment is estimated to be valued at US$ 34.2 Mn by the end of 2016

The latex gloves segment is expected to account for the largest market share of 79.8% by 2016 end and is anticipated to increase at a CAGR of 9.3% from 2016 to 2026 in terms of value. The nitrile rubber material gloves segment is estimated to be valued at US$ 12.8 Mn by the end of 2016, exhibiting the highest CAGR of 10.2% over the forecast period

The disposable medical gloves segment is expected to account for the largest market share of 90.7% by 2016 end. However, the re-usable medical gloves segment is anticipated to register the highest CAGR of 9.5% over the forecast period

Among the end use segments, the hospital segment is expected to account for the highest gloves consumption and a higher value generation – reaching a valuation of US$ 66.3 Mn by the end of 2016 and registering a CAGR of 9.3% over the forecast period

Regional market projections

The GCC medical gloves market is segmented into the top six countries of Saudi Arabia, United Arab Emirates, Qatar, Bahrain, Oman, and Kuwait. In terms of revenue share, the Kingdom of Saudi Arabia is expected to dominate the GCC medical gloves market, accounting for the largest market share of 75.8% by 2016 end. Revenue generated from the Saudi Arabia medical gloves market was pegged at US$ 70.0 Mn in 2015 and is anticipated to increase to US$ 184.6 Mn by the end of the forecast period. The UAE medical gloves market is estimated to account for US$ 18.6 Mn value share by 2016 end and is expected to register a CAGR of 9.0% over the forecast period to reach US$ 44.1 Mn by 2026. The Qatar and Bahrain markets are expected to exhibit modest growth in the GCC medical gloves market during the forecast period.

Need more information about Report methodology ? @ https://www.futuremarketinsights.com/askus/rep-gc-1943

Vendor insights

Some of the major players in the GCC medical gloves market are Paul Hartmann AG, Hotpack Packaging Industries, LLC, Falcon (Falcon Pack), Deeko Bahrain, Salalah Medical Supplies Mfg. Co. LLC, United Medical Industries Co. Ltd., and NAFA (NAFA Enterprises, Ltd.).

"Top market companies are focussed on expanding their customer base by implementing strategies such as mergers and acquisitions, inorganic growth, horizontal integration, and capacity expansion." Analyst - Healthcare, Pharmaceuticals and Medical devices, Future Market Insights

 

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Tip Location Devices Market Segmentation, By Product Type - Tip Location Systems and Accessories; By End User - Hospitals, Ambulatory Surgical Centres and Catheterisation Labs

Valley Cottage, NY -- (SBWIRE) -- 11/26/2018 -- Tip location devices are being increasingly used for confirmation of PICC tip location during PICC insertion, owing to their advantages, such as meticulous precision and low-price. Tip location devices are emerging as a credible alternative to the more expensive methods used for PICC tip confirmation, such as X-ray and fluoroscopy. These factors are expected to fuel the growth of the US$ 27 Mn global tip location devices market, according to a new report by Future Market Insights (FMI). The report, titled, "Tip Location Devices Market: Global Industry Analysis and Opportunity Assessment, 2016-2026", projects 6.4% CAGR for the global tip location devices market during the forecast period 2016-2026.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-880 

FMI's report offers market forecast and analysis on the global tip location devices market, segmenting the market on the basis of product, technology, end-user, and region.

North America Largest Market Globally

According to FMI's region-wise analysis, North America (U.S. and Canada) is the most lucrative market for tip location devices globally. The region accounted for 42.2% revenue share of the global tip location devices market in 2015, and is expected to increase at 7.1% CAGR during the forecast period, 2016-2026. Asia Pacific excluding Japan (APEJ), an emerging market for tip location devices, accounted for 8.0% revenue share of the market in 2015.

On the basis of product, FMI's report has segmented the market into tip location devices and accessories. The former dominates global revenues in terms of value, whereas the latter has higher market share in terms of volume.

On the basis of technology, the tip location devices market has been segmented into ECG tip confirmation, ECG with magnetic tracking and ECG & intravascular Doppler. Tip location devices that use ECG & intravascular Doppler technology are expected to witness higher demand than devices that use only ECG technology and devices that use ECG with magnetic tracking.

Key end-use sectors that generate the bulk of demand for tip location devices can be broadly categorised into hospitals, ambulatory surgical centres, and catheterization labs. Among these, hospitals account for the largest revenue share of the market, owing to increasing number of PICC insertion procedures carried out in hospitals.

Need more information about Report methodology ? @ https://www.futuremarketinsights.com/askus/rep-gb-880 

Key companies profiled in FMI's report include C.R. Bard, Inc., Teleflex Incorporated, AngioDynamics Inc., Vygon S.A. and CORPAK MedSystems

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Neurointerventional Devices Market Segmentation By Product – Embolic Coils, Carotid Stents, Intracranial Stents, Neurovascular Thrombectomy, Embolic Protection, Flow Diverters Devices, Intrasaccular Devices, Liquid Embolic Devices, Balloons, Stent Retrievers; By Technique – Neurothrombectomy, Cerebral Angiography, Stenting, Coiling Procedure, Flow Disruption; By End-Use – Hospitals, Ambulatory Surgical Centres

Valley Cottage, NY -- (SBWIRE) -- 11/23/2018 -- Future Market Insights (FMI), in its latest report titled, "Neurointerventional Devices Market: Global Industry Analysis and Opportunity Assessment 2015 – 2025", has projected global neurointerventional devices market to expand at a CAGR of 4.8% during the forecast period (2015-2025).

As per the Society of Neurointerventional Surgery, neurointervention is a treatment approach to conditions occurring within the blood vessels of the brain or in the spinal cavity. This procedure is highly performed by neuro-specialists due to its safety, minimally-invasive technique and comparatively higher success rate ratio as compared to conventional clipping method.

Global neurointerventional devices market is estimated to account for US$ 1,766.8 Mn by the end of 2015, mainly driven by rising demand from end-use segments.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-871 

The report analyses the global neurointerventional devices market in terms of market value (US$ Mn) and market volume (units) by product type, region, end-user and technique, and provides information regarding market dynamics, regulatory compliances, competitive landscape, current trends, market estimations and forecast for the market.

Adoption rate of neurointervention devices among neurosurgeons/neuro-specialists has increased significantly owing to the technological advancements and benefits these devices offer. These devices, especially metal coils and catheters, are highly preferred by neurosurgeons. Increasing geriatric population globally is also expected to boost overall demand for neurointerventional devices. These devices find wide application in Japan and countries in developed regions such as Western Europe and North America. However, these devices are expected to gain popularity in Latin America and Asia Pacific excluding Japan (APEJ) in the near future. High cost along with negative perception about certain neurointervention devices are factors that are expected to act as growth restraints in the future, and some devices approval by FDA have also faced criticism for performance.

North America is expected to dominate the global market throughout 2025 and is projected to witness 1.6X increase in volume over the forecast period. The U.S is expected to dominate the North America neurointerventional devices market throughout the forecast period. However, the U.S. market is projected to lose significant amount of its market value share to Canada by the end of forecast period.  North America is a major neurovascular market. The region is expected to witness launch of various new products, with increasing number of players expected to enter into the market over the following five years. Japan is the next most lucrative market for neurovascular companies; however, the market in the region is projected to witness below average CAGR of 3.9% during the forecast period.

Among product types, embolic coils product segment is expected to dominate the global neurointerventional devices market, followed by the neurothrombectomy product segment. Increasing incidence of brain aneurysm is expected to boost overall demand for embolic coils albeit, at a comparatively lower pace. Flow diverters and stent retrievers are gaining wide recognition among neurointerventionists. Stent retrievers segment is expected to witness impressive growth in the U.S. market over the following five years. Global stent retrievers segment is expected to witness 2X increase in value over the forecast period.

On the basis of technique, neurointervention devices market is segmented into neurothrombectomy procedure, cerebral angiography, stenting, coiling procedures and flow disruption. Coiling procedure segment is expected to dominate the overall neurointerventional devices market by the end of forecast period. The segment is projected to register average growth rate over the forecast period. Flow disruption is projected to be the fastest growing procedure segment. Increasing adoption of flow diverters among neurointervention is fuelling growth of the procedure segment.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-871 

On the basis of end use, the market has been segmented into hospitals and ambulatory surgical centers. Hospitals segment accounts for major share of the neurointerventional devices market.

Key market participants covered in the report include Medtronic, Penumbra Inc., Stryker Corporation, Terumo Corporation, and Johnson & Johnson.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Respiratory Inhaler Devices Market By Product – Dry Powder Inhaler, Metered Dose Inhaler, Nebulizer; By Technology – Manually Operated, Digitally Operated; By Disease Indication – Asthma, COPD, Pulmonary Arterial Hypertension

NYv, NY -- (SBWIRE) -- 11/23/2018 -- Future Market Insights (FMI) delivers key insights on the global respiratory inhaler devices market in its upcoming outlook titled, "Respiratory Inhaler Devices Market: Global Industry Analysis and Opportunity Assessment, 2015 – 2025". In terms of value, the global respiratory inhaler devices market is projected to register a healthy CAGR of 4.3% during the forecast period due to various factors. This FMI report offers vital and detailed insights regarding these factors.

The respiratory inhaler devices market is segmented on the basis of product type, disease indications, technology and region. Based on the product segmentation, the overall market has been categorised into metered dose inhaler (MDI), dry powder inhaler (DPI) and nebuliser.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-493

Nebulisers are further sub-segmented into ultrasonic nebuliser, mesh nebuliser and compressed air nebuliser. The metered dose inhaler segment is estimated to account for maximum share in the global respiratory inhaler devices market by 2015 end, and expected to register a CAGR of 4.5% in terms of value during the forecast period 2015-2025. Currently, metered dose inhaler is a major contributor to market growth in Europe, North America and parts of Asia Pacific. Demand for nebulisers is expected to expand at a CAGR of 3.8% through 2025.

Increase in prevalence of asthma, COPD and other respiratory disorders, especially among paediatric and the geriatric population, is a major factor driving growth of the global respiratory inhaler devices market. Other driving factors include strategic alliances among key players in the market, manufacturers focusing on enhancing market share, and expansion of the healthcare sector in developing countries due to growing investments by major players. Further, surge in demand for respiratory inhaler devices in all acute and moderate asthma and COPD conditions owing to increasing health awareness and growing disposable income is projected to result in increased spending on respiratory inhaler devices. This in turn is expected to bolster respiratory inhaler devices market growth during the forecast period.

Lack of effective drugs for certain respiratory disorders, concerns about side-effects and complications, lack of skilled pulmonologists and healthcare professionals, lack of awareness among patients, and high prices of inhaler devices are the key factors hampering growth of this market.

Currently, combined therapies offer more associated benefits, such as reliablility, increased efficacy, and favourable reimbursement policies. Owing to these factors, patients with complex respiratory disorders are more inclined towards adopting such therapies.

However, the cost associated with combination therapies is higher as compared to conventional therapies for patients with complex respiratory disorders. The global respiratory inhaler devices market is expected to be driven by the increased usage of newly introduced triple combination therapy for COPD patients in the coming years.

This report assesses trends driving each segment and offers analysis and insights about the potential of respiratory inhaler devices market in specific regions. North America is estimated to dominate the respiratory inhaler devices market with maximum market share by end of 2015. North America and Western Europe are collectively expected to account for over 64.1% of the total respiratory inhaler devices market share in terms of value by end of 2015. Asia Pacific excluding Japan is estimated to witness highest CAGR of 5.0% over the forecast period, followed by North America, due to increasing prevalence of asthma and COPD among children and the geriatric population.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-493

Some key companies covered in this report include AstraZeneca, Boehringer Ingelheim GmbH, GlaxoSmithKline plc, Cipla Ltd., Koninklijke Philips N.V., PARI Medical Holding ,Teva Pharmaceutical Industries Ltd., Beximco Pharmaceuticals Ltd., OMRON Healthcare Europe B.V. and Merck & Co., Inc.

Their primary focus is towards enhancing their product portfolio through research and development, introduction of innovative and cost-effective drugs and medical devices in order to gain market share and to strengthen their respective position in the global market.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

U.S. compounding pharmacies market segmentation by product type - oral medication, topical medication, mouthwashes medication, suppositories; by application - adult, veterinary, children, geriatric; by therapeutic - pain management, hormone replacement; Others - Market Size, Growth, Forecast, Sales, Pricing Forecast, Share, Export Value, Export Volume, Trade

Valley Cottage, NY -- (SBWIRE) -- 11/23/2018 -- Future Market Insights (FMI), in its latest report titled "Compounding Pharmacies Market: U.S. Industry Assessment and Forecast; 2015–2021", has projected the U.S. compounding pharmacies market to expand at a CAGR of 5.7% during the forecast period (2015–2021).

Compounding pharmacies are pharmacies that produce drugs tailored to needs of individual patients, by altering, combining, or mixing active pharmaceutical ingredients of drugs. Compounded drugs are prepared under prescription from physicians. Compounding includes combination of two or more drug ingredients in varied proportions. Most regulatory agencies across the world do not approve compounded medications, and do not verify the safety or effectiveness of compounded drugs. These drugs are usually not reimbursed by pharmaceutical benefit agencies.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-us-978

Compounding pharmacies in the U.S. are estimated to account for market value of US$ 3,262.6 Mn by the end of 2015, and is projected to witness stable growth due to rising demand for personalized medicines from customers.

The report analyses the U.S compounding pharmacies market in terms of market value (US$ Mn) by product, application and therapeutic area, and provides information regarding market dynamics, value chain, competitive landscape, current trends, market estimations and forecast.

The prime driver for the compounding pharmacies market is medicinal drought. Currently, there's a shortage of over 300 drugs for various diseases in the U.S. When the need for critical drugs are not met through commercially-available branded equivalents, compounded drugs are sought after. Furthermore, increasing demand for anti-aging products that use custom compounded drugs is a prevalent trend across the globe. Innovative sub-therapeutic areas such as bio-identical hormone replacement therapy are also contributing to growing popularity of compounded drugs.

On the basis of product type, the U.S. compounding pharmacies market is segmented into oral medication, topical medication, mouth washes, and suppositories.

Oral medications, constituting drugs that can be swallowed, are expected to exhibit stable growth rates ranging from 4.7% to 8.4% over 2015–2021.

Topical medications constitutes skin-application medications. Expected drivers for topical medication include rising popularity of innovative and promising personalized skin creams. Creams are most popular due to ease of preparation and also longer shelf-life. Ease of product composition even after combining two or three APIs customizes the drug and reduces manufacturing cost. Hence, price range varies significantly, i.e., from US$ 100 to 9,000 and above. Creams are mainly used for minimizing scars, skin irritations and other dermatological concerns and reducing pain at location, where oral dosages are not possible.

Mouthwashes and suppositories are expected to witness slightly lower growth rates owing to formulation rigidity emerging from regulatory restrictions. Popularity of non-sterile products is projected to increase due to increased product safety regulations imposed by the U.S. FDA.

On the basis of application, the U.S. compounding pharmacies market is segmented into medications for adults, veterinary, children, and geriatric population. Among the different application areas, medication for adults is expected to register highest attractiveness index as compared to other application areas during the forecast period. Medication for adults constitute drugs for critical illnesses such as cardiovascular diseases and cancer. Medications for adults are expected to increase owing to more people adopting compounded drugs, as these can be customized as per needs of individual patients.

On the basis of therapeutic area, the U.S. compounding pharmacies market is segmented into pain management and hormone replacement therapy (HRT). Among the two therapeutic area segments, HRT is expected to register highest CAGR as compared to pain management during the forecast period. HRT is expected to gain popularity owing to increasing awareness across the world due to its various benefits associated with age-defying therapies and products to bettering individual health.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-us-978

Key market participants covered in the report include PharMEDium Services, LLC, Institutional Pharmacy Solutions, Cantrell Drug Company, and Triangle Compounding Pharmacies

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Growth of the global digital wound measurement devices market is mainly driven by increase in prevalence of chronic disease, growth in ageing population and rising product innovation.

Valley Cottage, NY -- (SBWIRE) -- 11/23/2018 -- Future Market Insights (FMI) delivers key insights on the global digital wound measurement devices market in its upcoming outlook titled, "Digital Wound Measurement Devices Market: Global Industry Analysis and Opportunity Assessment, 2015 – 2025". In terms of value, the global digital wound measurement devices market is projected to register a healthy CAGR of 4.7% during the forecast period due to various factors, about which, FMI's report offers vital and detailed insights.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-717

The market is segmented on the basis of wound type, end user and region. On the basis of wound type, the market has been segmented into diabetic ulcer, chronic wounds, burns, incisional wounds and traumatic wounds. The diabetic ulcer segment is estimated to account for 43.1% share of the global digital wound measurement devices market by end of 2015, and is expected to register a CAGR of 5.0% in terms of value during the forecast period (2015–2025). In terms of revenue, Asia Pacific excluding Japan (APEJ), North America and parts of Western Europe are estimated to be major contributors to the diabetic ulcer segment by the end of 2015. Increasing prevalence of chronic diseases and growing ageing population are projected to further fuel market growth during the forecast period. The burns segment is expected to exhibit a CAGR of 5.5% in terms of value during the forecast period.

Growth of the global digital wound measurement devices market is primarily driven by increase in prevalence of chronic diseases, growth in geriatric population and product innovation. The trends which are driving the growth of this market are like, players in this market are continuously developing and introducing newer and advanced medical devices and products through technological innovation, to cater to steadily increasing shift from traditional wound measurement devices to newer and more advanced options.

Other trends driving market growth include extensive research and development by key players in the market, manufacturers eyeing intravenous digital wound measurement devices market share and expansion of healthcare sector in Asia Pacific due to growing investments by major players. Moreover, players in the market are continuously developing and introducing new and advanced medical devices and products through technological innovation to cater to steadily increasing shift from traditional wound measurement devices to advanced options. This in turn, is expected to bolster digital wound measurement devices market growth during the forecast period.

This report assesses trends driving each segment and offers analysis and insights about the potential of digital wound measurement devices market in specific regions. North America is estimated to dominate the digital wound measurement devices market with 43.7% share by the end of 2015. Western Europe and APEJ are collectively expected to account for over 45.4% of the total digital wound measurement devices market share, in terms of value by end of 2015. The APEJ market is projected to witness the highest CAGR of 4.2% over the forecast period,followed by Eastern Europe. North America is expected to dominate the digital wound measurement devices market with 45.5% market share by end of 2025. Chronic wound type segment is expected to account for US$ 513.1 thousand by end of 2025.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-717

Key players in the global digital wound measurement devices market covered in the report, namely, ARANZ Medical and Wound Zoom Inc. focus on making substantial investments in research and development activities to enhance the digital wound measurement devices quality,minimiseside effects and maximize efficacy, in order to gain competitive advantage and create high entry barriers for new players attempting to enter the digital wound measurement devices market.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Growth of the global general anesthesia drugs market is mainly driven by rising incidences of cardiovascular diseases, chronic respiratory diseases, craniomaxillofacial surgeries and accidents.

Valley Cottage, NY -- (SBWIRE) -- 11/23/2018 -- Future Market Insights (FMI) delivers key insights on the global general anaesthesia drugs marketin its upcoming outlook titled, "General Anaesthesia Drugs Market: Global Industry Analysis and Opportunity Assessment, 2015 – 2025". In terms of value, the global General Anaesthesia Drugs market is projected to register a healthy CAGR of 3.8% during the forecast period due to various factors, FMI's report offers vital and detailed insights about the said factors.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-388

The market is segmented on the basis of product and region. On the basis of product, the market has been segmented in to: Propofol, Sevoflurane, Dexmedetomidine, Desflurane, Remifentanil, Midazolam and Others. The Propofol segment is estimated to account for 29.8% share of the global general anaesthesia drugs market by end of 2015, and is expected to register a robust CAGRs of 5.4% in terms of value during the forecast period. In terms of revenue, Propofol is currently witnessing major contribution from Asia Pacific, North America and parts of Western Europe. Increasing incidences of cardiovascular disease related surgeries are likely to further fuel market growth during the forecast period. Sevoflurane segment is expected to exhibit a CAGR of 4.6% in terms of value during the forecast period.

Growth of the global General Anaesthesia Drugs market is primarily driven by increasing incidence of surgeries related to cardiovascular diseases, accidents, carniomaxillofacial deformities, chronic respiratory disease, and joint replacement surgeries, especially among the geriatric population. Other trends driving market growth include strategic alliances among key players in the market, manufacturers eyeing intravenous general anaesthesia drugs market share, and expansion of healthcare sector in developing countries due to growing investments by major players. In addition, surge in demand for general anaesthesia drugs in all major and moderate surgeries owing to increasing health awareness and growing disposable income is projected to result in increased spending on general anaesthesia drugs. This in turn, is expected to bolster general anaesthesia drugs market growth during the forecast period (2015–2025).

This report assesses trends driving each segment and offers analysis and insights about the potential of general anaesthesia drugs market in specific regions. North America is estimated to dominate the general anaesthesia drugs market with 31.0% market share by end of 2015. North America and Western Europe are collectively expected to account for over 56.9% of the total general anaesthesia drugs market share, in terms of value by end of 2015. The Asia Pacific excluding Japan market is estimated to witness the highest CAGR of 5.2% over the forecast period, followed by Latin America due to increasing incidences of surgeries related to cardiovascular and chronic respiratory diseases. Asia Pacific excluding Japan is expected to dominate the general anaesthesia drugs market with 31.1% market share by end of 2025. Sevoflurane is mostly used for maintaining the sedative stage in patients during the surgical procedure, and is expected to account for US$ 1,257.0 Mn by end of 2025.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/askus/rep-gb-388

Key players of the global general anaesthesia drugs market such as: Baxter International Inc., AstraZeneca, AbbVie Inc., B. Braun Melsungen AG, Fresenius SE & Co. KGaA, and Hospira Inc. focus on making substantial investments in research and development to enhance the general anaesthesia drug quality by minimize side effects and maximize efficacy, in order to offer competitive advantage and create high entry barriers for new players attempting to enter the general anaesthesia drugs market

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

US$ 56.7 Mn Worth of Hemostats Expected to be Sold in India in 2016, Demand for Mechanical Hemostats to Remain Strong

Valley Cottage, NY -- (SBWIRE) -- 11/22/2018 -- Hemostat is a chemical agent that is used for wound closure and prevents from excessive blood flow. Hemostats are highly effective products used during surgeries and operations to control blood loss. These products come in different forms such as sponges, gauzes, strips, films, powders and others. Increasing geriatric population and rising adoption of hemostat products by medical practitioners is expected to drive growth of the India hemostat market. However, there is low acceptance among medical practitioners and healthcare professional owing to low awareness. Hence, creating awareness among key opinion leaders such as healthcare professionals could open up opportunities for growth of the India hemostat market in the near future.

Market Value and Forecast

In 2015, the Indian hemostat market was valued at US$ 54.1 Mn and is expected to expand at a CAGR of 5.8% over 2016–2025. This expected growth is attributed to advancements in hemostat products and increasing adoption of hemostat products by medical practitioner and surgeons, fuelled by an increase in number of surgeries and trauma cases across the country.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-in-1518 ? 

Market Dynamics

Economic factors such as rise in disposable income and provision of medical reimbursement policies are expected to drive market growth in the country. Surgeons shifting from traditional to new conventional methods for blood clotting is fuelling growth of hemostat market in India. However, various factors such as lower awareness of hemostat, high priced products and government regulations for hemostat is expected to inhibit market growth.

Market Segmentation by Product Type

By product type, the India hemostat market is segmented into mechanical type and flowable type. Mechanical type segment includes gauzes, sponges, strips and films, and flowable type includes powder type segment. Currently, the mechanical type segment accounts for highest market share in the India hemostat market, and is expected to continue to remain the dominant type in terms of value during the forecast period as preference for this type among healthcare professional is high.

Market Segmentation by Product Material Form

By product material form, the hemostat market is segmented into gelatin material and oxidised cellulose material segments. Gelatin material is used for manufacturing gauzes, sponges, films, strips and powder and oxidised cellulose is used in hemostat strips. Currently the gelatin material form accounts for highest market share in the India hemostat market, and this trend is expected to continue in terms of value during the forecast period. This is attributed to high preference among healthcare professionals for this type of product as it absorbs blood more quickly. 

Market Segmentation by Application

In terms of application, hemostat are used during surgeries and this segment is expected to account for over 50% of the revenue generated in the India's hemostat market. Revenue from the trauma cases is expected to increase at the highest CAGR over the forecast period as compared to surgeries.

Need more information about Report methodology ? @ https://www.futuremarketinsights.com/askus/rep-in-1518 

Market Segmentation by Distribution Channel

By distribution channel, hospital segment is expected to register an exceptional CAGR during the forecast period owing to increase in adoption rate of hemostat products and acceptance of these products by surgeons and medical practitioners.  Ambulatory surgical centre segment is expected to exhibit a constant market share owing to high patient inflow at ASCs due to reimbursement for surgeries from insurance payer, which will result in decreased healthcare expenditure.

Key Players

Key market players covered in this report are Johnson and Johnson (Ethicon), Baxter, Aegis Lifesciences, Eucare Pharmaceuticals and Mil Laboratories.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Increasing women workforce coupled with technological advancement fuelling demand for breast pumps among customers, finds a FMI Study

Valley Cottage, NY -- (SBWIRE) -- 11/22/2018 -- The FMI Study titled "Breast Pump Market - Global Industry Analysis 2012–2016 and Opportunity Assessment 2016–2026", highlights the potential factors fuelling the revenue growth of the breast pump market globally. A breast pump is a medical device used to elicit breast milk from lactating women. Breast pump products are available in two models, including manual breast pumps and electrical breast pumps. Electric breast pumps are available in two formats: single electric breast pumps and double electric breast pumps. This report analyzes total revenue generated through sales of breast pump products, which include manual breast pumps and electric breast pump devices for breast feeding. Breast pump products are increasingly becoming a necessity among working women across the world as the inclusion of women in workforce is increasing globally.

Emerging economies are witnessing impressive growth in healthcare spending. This can be attributed to improvements in healthcare technology and changing lifestyle, which is fuelling the demand for breast pumps among urban women. According to WHO, the global healthcare spending rose by 2.4% in 2014 over 2013. Healthcare spending is growing at a rate of 5% in developing regions. Rise in healthcare expenditure is expected to boost overall adoption of breast pumps among women, especially in Asia Pacific. Breast pump adoption is as high as 85% among breast feeding women at 3 months post-birth.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-967 

Furthermore, marketplace discussions indicate that the availability of breast pump accessory products will also encourage the adoption of electric breast pumps in developed markets. In this regard, infant product manufacturers are increasingly bundling other pump-related products, such as nursing bras and breast pumping bras, to sell complete package of breast pumps, which is anytime more profitable than isolated sales. Electrical breast pump packages find more adoption than manual breast pump products due to better volume of output. These innovative solutions are projected to fuel breast pump market revenues in the global electric breast pumps market during the forecast period.

The Electric breast pump market is more technologically advanced with higher product pricing and low penetration. This category of breast pump comprises few global breast pump manufacturing companies. Potential new entrants in breast pump market are trying to capture and improve their market position by using innovative marketing strategies, such as inorganic growth. Breast pump manufacturers are expanding their product portfolio using latest technologies.

Availability of BPA free breast pump products is fuelling breast pump adoption in developed as well as more the affluent markets in developing regions. In the recent past, breast pump manufacturers have begun offering bisphenol A or BPA-free breast pump products to increase sales. BPA is a chemical used to make milk container or feeding bottle rigid and more resistant and has been associated with adverse health effects, such as neural and fertility issues. Examples of some BPA free breast pump products are Philips Avent Manual Comfort Breast Pump from Koninklijke Philips N.V. and BPA-free breast pumps by Medela, Inc.

Rapid rise in promotional/supporting campaigns for Breast Pump products is fuelling revenue growth of the breast pump market. In November 2012, leading breast pump manufacturer Medela launched a campaign titled 'Virtual Human Milk Collection Campaign' to commemorate Prematurity Awareness Month, where the breast pump manufacturer encouraged and demonstrated the importance of breast milk for infants and babies. Medela has also donated US$ 30,000 worth of breastfeeding related products to various neonatal intensive care units across the U.S.

Need more information about Report methodology ? @ https://www.futuremarketinsights.com/askus/rep-gb-967 

Some of the leading breast pump manufacturing companies analyzed in the report include Koninklijke Philips N.V., Pigeon Corporation, Newell Brands, Medela Inc., Ameda Inc., Hygeia II Medical Group Inc., Bailey Medical, Mayborn Group Ltd. and Linco Baby Merchandise Works Co., Ltd.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

India coronary stents market is estimated to be valued at US$ 531 Mn by 2016 end and is expected to expand at a CAGR of 14.0% over the forecast period (2016–2026)

Valley Cottage, NY -- (SBWIRE) -- 11/22/2018 -- India coronary stents market, valued at US$ 481 Mn in 2015, is expected to reach US$ 531 Mn in revenues by 2016-end, according to a new research report by Future Market Insights. The report titled, "Coronary Stents Market: India Industry Analysis and Opportunity Assessment, 2016-2026" projects the market to increase at 14% CAGR through 2026 and surpass US$ 1.8 Bn in revenues. 

Demand for coronary stents is expected to be driven by government initiatives to offer better healthcare amenities. Capping of coronary stents prices, increase in geriatric population, and increasing number of PCI procedure to treat CHD are other key factors anticipated to fuel demand for coronary stents during the forecast period.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-in-1485 ?

Easing of norms such as exemptions in direct taxes, while allowing 100 percent FDI in medical devices segment under the automatic route is expected to encourage entry of foreign players in the healthcare sector in the near future.

Increasing prevalence of diabetes is high among the ageing population in the country. In 2014, 43.2% of the sampled population in the country was aware about diabetes and related treatment options. Over the last few years, number of PCI procedures have increased in India due to increase in prevalence of CHD.

India coronary stents market is segmented on the basis of product type, raw material and end-use.

On the basis of product type, the market has been segmented into Drug Eluting Stent (DES), Bare Metal Stent (BMS) and Bioresorbable Vascular Stent (BVS). Drug Eluting Stent segment is expected to register impressive CAGR of 14.0% during the forecast period.

On the basis of raw material, the market is segmented into cobalt-chromium, stainless steel, platinum-chromium, nickel-titanium and polymer. Currently, demand for cobalt-chromium is the highest, followed by platinum-chromium.

On the basis of end use, India coronary stents market is segmented into hospitals, ambulatory surgical centres and cardiac catheterization laboratories. By end use, hospitals segment is expected to witness fastest growth during the forecast period.

Need more information about Report methodology ? @ https://www.futuremarketinsights.com/askus/rep-in-1485 

The key players profiled in FMI's report include Abbott Laboratories, Medtronic, Inc., Biosensors Inc., and Boston Scientific Inc. The report also identifies company-specific strategies related to product development, market consolidation initiatives and analysis of their specific strengths, weaknesses, opportunities and threats.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Antibodies Market: New Class Monoclonal Antibodies Contribute to Market Momentum, Finds FMI study

Valley Cottage, NY -- (SBWIRE) -- 11/22/2018 -- Growing number of innovative product launches and expansion of therapeutic indications for already approved antibody therapeutics will continue to drive the growth of the antibodies market. In biopharmaceutical drugs, monoclonal antibody-based therapeutics are the dominant form of biologic drugs -- 6 of 10 top-selling drugs in 2017 were antibodies. The antibodies market is expected to witness impressive growth due to growing new drug approvals across the globe. Number of antibody-based therapeutics granted first approval reached double-digits for the first time in 2017 and a total of 9 antibody candidates were undergoing regulatory review. Future Market Insights forecasts that the global antibodies market is projected to expand at a robust CAGR of 12.5% over 2016–2026.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1330 

Harmonization of international drug regulatory pathways is likely to be instrumental in driving the number of new antibody-based therapeutics approved for commercial sales in the US and Europe and thus, will be a strong driving factor for antibodies market. As the European Union (EU) and the U.S. possesses distinct but overlapping schemes for the biologics regulations, both the authorities are making harmonization efforts with respect to some of the technical requirements for biologic applications. As a result, regulatory procedures in two major markets are getting more streamlined to comply with common standards and practices between EMEA and U.S. FDA. Moreover, evolution of the clear regulatory approval process for biosimilar in emerging markets represents additional opportunity for antibody based products. This is expected to provide key contribution to the expansion of the antibodies market at a global front. Future Market Insights estimates that the global antibodies market value is expected to surpass US$ 341 Bn by 2026 end.

Significant technological advances in the fields of immunology and protein science are driving the development of antibody-based drugs in a range of therapeutic areas. Antibody-based drugs cover the big spread of disease indications, including autoimmune diseases, such as arthritis & transplant rejection, various cancers, dermatological disorders, hematological disorders and inflammatory diseases, among others.

Novel technologies will enhance the therapeutic potential of antibodies. Development of antibody drug conjugates (ADCs) and bispecific antibodies have opened up new opportunities in immunotherapeutic research. Since the FDA approval of first ADC in 2011, ADCs have become the major developmental candidates in the pipeline of many companies. Furthermore, diagnostic antibodies are increasingly gaining acceptance in diagnosis of certain conditions, such as myeloid & lymphoid malignancies, tissue typing, etc. This growth in antibodies as a therapeutic and diagnostic agent was made possible partly by the development of large-scale production techniques, such as mammalian cell culture, which allowed production in quantities that meet the market requirements.

Monoclonal antibodies segment is likely to witness significant traction in the coming years, in turn, immensely contributing to overall sales of antibodies market, says the report. Since the launch of first therapeutic monoclonal antibody in 1986, the class of monoclonal antibodies have expanded substantially so that, today over 74 monoclonal antibody based therapeutics have been approved for commercial use across the globe.

Based on company announcements and estimated primary completion dates, above 18 late stage clinical candidates of antibody drug class and marketing applications for 12 candidates are expected to be submitted to regulatory authorities (FDA & EU) by 2018 end. Percentage contribution of non-cancer monoclonal antibodies indication segment is rising steadily and collective revenue share of non-cancer antibodies is estimated to exceed 40% of global antibodies market by 2026 end.

Need more information about Report methodology ? @ https://www.futuremarketinsights.com/askus/rep-gb-1330 

Sales of antibody-based therapeutics and diagnostics is likely to remain concentrated in the regulated markets of Europe, the U.S. and Japan. However, the launch of biosimilar antibodies is expected to fuel the demand for antibody-based therapeutics in emerging markets. Asia Pacific excluding Japan (APEJ) market for antibodies lags behind in technology due to comparatively late beginning of clinical development of therapeutic antibodies in the region. As a result, currently approved and marketed products in APEJ are technologically outsourced from key players in established markets, such as Roche and Merck & Co.

Overall, the global antibodies market is highly competitive with over 22 big biopharma companies operating in it. Introduction of biosimilar antibodies has further increased the competition intensity in the last two years. Despite this, the global antibodies market is expected to gain significant momentum over the forecast period.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm